Home › Liver Cancer › California › San Francisco
Liver Cancer clinical trials in San Francisco, CA
6 studies for Liver Cancer are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
- Kaiser Permanente-San Francisco, San Francisco
National Liver Cancer Screening Trial
RecruitingPhase 4
- University of California, San Francisco, San Francisco
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
RecruitingObservational study
- Sutter Bay Hospitals, San Francisco
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
RecruitingPhase 1/2
- UCSF Benioff Children's Hospitals, San Francisco
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
RecruitingPhase 2
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, San Francisco
About Liver Cancer
The most common form of liver cancer in adults is hepatocellular carcinoma. Learn about diagnosis, treatment and taking part in research studies.
More about Liver Cancer on MedlinePlus
Liver Cancer trials in other cities
- Houston, TX14 studies
- Cleveland, OH11 studies
- Los Angeles, CA11 studies
- Dallas, TX10 studies
- Boston, MA9 studies
- Chicago, IL8 studies
- St. Louis, MO8 studies
- Durham, NC7 studies
- Philadelphia, PA7 studies
- New York City, NY6 studies
- Washington, DC6 studies
- Orange, CA6 studies
Other studies in San Francisco
- Prostate Cancer45 studies
- Breast Cancer43 studies
- Non-Small Cell Lung Cancer36 studies
- Cancer (all types)35 studies
- Heart Failure29 studies
- Metastatic Cancer28 studies
- Lung Cancer22 studies
- Melanoma22 studies
- Pancreatic Cancer20 studies
- Ovarian Cancer19 studies
- Colorectal Cancer18 studies
- Cardiovascular Disease18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.